妇科肿瘤学家在胎盘植入谱系疾病(PAS)剖宫产子宫切除术管理中的重要性
本研究为回顾性队列研究,纳入2010至2021年德克萨斯大学圣安东尼奥胎盘植入项目中122例单胎非畸形PAS妊娠行剖宫产子宫切除术者,其中妇科肿瘤学家主刀62例(50.8%)。妇科肿瘤学家更多参与产前诊断胎盘穿透性植入的复杂病例(11.7% vs 37.1%,p=0.001),这些病例复合母体发病率更高(65% vs 83.9%,p=0.02)。多因素分析控制混杂后,复合母体发病率无差异(aOR=0.95,95%CI 0.35-2.52),但术中酸中毒(aOR=0.36,95%CI 0.14-0.93)和术后住院>4天(aOR=0.37,95%CI 0.15-0.91)发生率更低。
要点
- 妇科肿瘤学家主刀PAS剖宫产子宫切除术的比例从16%升至80%。
- 妇科肿瘤学家更多处理产前诊断胎盘穿透性植入的复杂病例。
- 控制混杂后,妇科肿瘤学家主刀者术中酸中毒和术后住院>4天风险更低。
核心结论
- 妇科肿瘤学家在处理PAS剖宫产子宫切除术中发挥关键作用,相比妇产科专家,更可能作为主刀医生处理复杂病例,且母体发病率相似、术后结局更优。
研究设计与样本
- 回顾性队列研究,纳入2010至2021年德克萨斯大学圣安东尼奥胎盘植入项目中122例单胎、非畸形、并发PAS并接受剖宫产子宫切除术的妊娠。
主要发现
- 妇科肿瘤学家主刀62例(50.8%),其参与比例从16%增至80%。
- 妇科肿瘤学家更多参与产前诊断胎盘穿透性植入病例(11.7% vs 37.1%,p=0.001),这些病例复合母体发病率更高(65% vs 83.9%,p=0.02)。
- 妇科肿瘤学家主刀的手术时间更长(151 vs 271 min,p<0.0001),输尿管支架使用更多(36.7% vs 66.1%,p=0.002),术后住院更长(3 vs 4天,p<0.0001)。
- 妇科肿瘤学家主刀的PAS剖宫产子宫切除术较少采用子宫颈上切除术(25% vs 3.2%,p=0.0005)。
- 多因素分析控制胎盘穿透性植入、子宫动脉栓塞、阴道出血和急诊分娩后,复合母体发病率无差异(aOR=0.95,95%CI 0.35-2.52),术中酸中毒(aOR=0.36,95%CI 0.14-0.93)和术后住院>4天(aOR=0.37,95%CI 0.15-0.91)发生率更低。
临床怎么用
- 妇科肿瘤学家应参与PAS剖宫产子宫切除术的手术管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Placenta Accreta Spectrum (PAS) is an invasive placental disorder characterized by significant maternal and fetal morbidity. Utilization of multidisciplinary teams has been shown to optimize patient outcomes. Our objective was to assess the impact of cesarean hysterectomy performed by gynecologic oncologists versus Ob/Gyn specialists in maternal morbidity. METHODS: A retrospective cohort study was performed of singleton, non-anomalous pregnancies complicated by PAS University of Texas Health San Antonio Placenta Accreta program from 2010 to 2021. Our primary outcome was a maternal morbidity composite of any of the following: estimated blood loss >2 L, ICU admission, intraoperative acidosis and post-operative length of stay >4 days. In addition, demographic and pregnancy data were obtained. Univariate and multivariate analyses were performed to identify the individual impact of variables such as general anesthesia, episodes of vaginal bleeding, uterine artery embolization, emergent delivery and placenta percreta pathology. RESULTS: 122 pregnancies complicated by PAS who underwent cesarean hysterectomy were identified from 2010 to 2021. Gynecologic oncologists were the primary surgeons for 62 (50.8%) of these cases. The involvement of gynecologic oncologists increased over the time period from 16% to 80%. Gynecologic oncologists were more like to be involved in cases with an antenatal diagnosis of placenta percreta (11.7 vs 37.1%, p = 0.001) and these cases were characterized by increased composite maternal morbidity (65 vs 83.9%, p = 0.02). These cases were also significantly longer (151 vs 271 min, p < 0.0001), involved greater usage of urinary stents (36.7 vs 66.1%, p = 0.002) and had longer post-operative lengths of stay (3 vs 4 days, p < 0.0001). PAS cesarean hysterectomies by gynecologic oncologists were less likely to be supracervical (25 vs 3.2%, p = 0.0005). Multivariate analysis controlling for placenta percreta, uterine artery embolization, vaginal bleeding and emergent delivery showed no difference in composite maternal morbidity (aOR = 0.95, 95%CI [0.35-2.52]) and lower rates of intraoperative acidosis (aOR = 0.36, 95%CI [0.14-0.93]) or post-operative length of stay >4 days (aOR = 0.37, 95%CI [0.15-0.91]). CONCLUSIONS: Gynecologic oncologists play a critical role in the surgical management of PAS cesarean hysterectomies. When compared to Ob/Gyn specialists, gynecologic oncologists are more likely to act as primary surgeons in complex cases similar morbidity and greater post-operative outcomes.
引用
- Munoz JL, Blankenship LM, Ramsey PS, et al. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS). Gynecol Oncol. 2022. PMID: 35781164. doi:10.1016/j.ygyno.2022.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。